Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues

In the 1990s, tumour necrosis factor-α inhibitor therapy ushered in the biologic therapy era for inflammatory bowel disease, leading to marked improvements in treatment options and patient outcomes. There are currently four tumour necrosis factor-α inhibitors approved as treatments for ulcerative co...

Descripción completa

Detalles Bibliográficos
Autores principales: Peyrin-Biroulet, Laurent, Sandborn, William J., Panaccione, Remo, Domènech, Eugeni, Pouillon, Lieven, Siegmund, Britta, Danese, Silvio, Ghosh, Subrata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669878/
https://www.ncbi.nlm.nih.gov/pubmed/34917173
http://dx.doi.org/10.1177/17562848211059954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669878/
https://www.ncbi.nlm.nih.gov/pubmed/34917173
http://dx.doi.org/10.1177/17562848211059954

Ejemplares similares